{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:05:18Z","timestamp":1793084718112,"version":"4.5.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H02655, 19H01042, 22H00464"],"award-info":[{"award-number":["16H02655, 19H01042, 22H00464"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23gm1910001h0001"],"award-info":[{"award-number":["23gm1910001h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["22110001, 22110002"],"award-info":[{"award-number":["22110001, 22110002"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Better understanding of the earliest molecular pathologies of all neurodegenerative diseases is expected to improve human therapeutics. We investigated the earliest molecular pathology of spinocerebellar ataxia type 1 (SCA1), a rare familial neurodegenerative disease that primarily induces death and dysfunction of cerebellum Purkinje cells. Extensive prior studies have identified involvement of transcription or RNA-splicing factors in the molecular pathology of SCA1. However, the regulatory network of SCA1 pathology, especially central regulators of the earliest developmental stages and inflammatory events, remains incompletely understood. Here, we elucidated the earliest developmental pathology of SCA1 using originally developed dynamic molecular network analyses of sequentially acquired RNA-seq data during differentiation of SCA1 patient-derived induced pluripotent stem cells (iPSCs) to Purkinje cells. Dynamic molecular network analysis implicated histone genes and cytokine-relevant immune response genes at the earliest stages of development, and revealed relevance of ISG15 to the following degradation and accumulation of mutant ataxin-1 in Purkinje cells of SCA1 model mice and human patients.<\/jats:p>","DOI":"10.1038\/s42003-024-06066-z","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T06:02:06Z","timestamp":1712642526000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Dynamic molecular network analysis of iPSC-Purkinje cells differentiation delineates roles of ISG15 in SCA1 at the earliest stage"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3175-7463","authenticated-orcid":false,"given":"Hidenori","family":"Homma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7931-0313","authenticated-orcid":false,"given":"Yuki","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8384-8143","authenticated-orcid":false,"given":"Kyota","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9992-5254","authenticated-orcid":false,"given":"Shinichi","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Hama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Komano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1734-7997","authenticated-orcid":false,"given":"Ichiro","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7482-5935","authenticated-orcid":false,"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidenao","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2602-8226","authenticated-orcid":false,"given":"Hikari","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6127-5046","authenticated-orcid":false,"given":"Hitoshi","family":"Okazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,9]]},"reference":[{"key":"6066_CR1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","volume":"27","author":"S Salloway","year":"2021","unstructured":"Salloway, S. et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer\u2019s disease. Nat. Med. 27, 1187\u20131196 (2021).","journal-title":"Nat. Med."},{"key":"6066_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/srep31895","volume":"6","author":"K Fujita","year":"2016","unstructured":"Fujita, K. et al. HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer\u2019s disease. Sci. Rep. 6, 31895 (2016).","journal-title":"Sci. Rep."},{"key":"6066_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14353-6","volume":"11","author":"H Tanaka","year":"2020","unstructured":"Tanaka, H. et al. YAP-dependent necrosis occurs in early stages of Alzheimer\u2019s disease and regulates mouse model pathology. Nat. Commun. 11, 507 (2020).","journal-title":"Nat. Commun."},{"key":"6066_CR4","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","volume":"25","author":"J-H Lee","year":"2022","unstructured":"Lee, J.-H. et al. Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of A\u03b2 in neurons, yielding senile plaques. Nat. Neurosci. 25, 688\u2013701 (2022).","journal-title":"Nat. Neurosci."},{"key":"6066_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/s41586-022-05491-6","volume":"612","author":"P Yuan","year":"2022","unstructured":"Yuan, P. et al. PLD3 affects axonal spheroids and network defects in Alzheimer\u2019s disease. Nature 612, 328\u2013337 (2022).","journal-title":"Nature"},{"key":"6066_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH Van Dyck","year":"2023","unstructured":"Van Dyck, C. H. et al. Lecanemab in Early Alzheimer\u2019s Disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"6066_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","volume":"4","author":"HT Orr","year":"1993","unstructured":"Orr, H. T. et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 4, 221\u2013226 (1993).","journal-title":"Nat. Genet."},{"key":"6066_CR8","doi-asserted-by":"crossref","unstructured":"Zoghbi, H. Y. & Orr, H. T. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, Spinocerebellar ataxia type 1. J. Biol. Chem. 284, 7425\u20137429 (2009).","DOI":"10.1074\/jbc.R800041200"},{"key":"6066_CR9","doi-asserted-by":"crossref","unstructured":"La Spada, A. R. Neurodegeneration: A Case of Arrested Development? Cell 127, 669\u2013671 (2006).","DOI":"10.1016\/j.cell.2006.11.010"},{"key":"6066_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cell.2006.09.036","volume":"127","author":"HG Serra","year":"2006","unstructured":"Serra, H. G. et al. ROR\u03b1-Mediated Purkinje Cell Development Determines Disease Severity in Adult SCA1 Mice. Cell 127, 697\u2013708 (2006).","journal-title":"Cell"},{"key":"6066_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01790-z","volume":"8","author":"K Fujita","year":"2017","unstructured":"Fujita, K. et al. Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1. Nat. Commun. 8, 1864 (2017).","journal-title":"Nat. Commun."},{"key":"6066_CR12","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1073\/pnas.0400615101","volume":"101","author":"C-C Tsai","year":"2004","unstructured":"Tsai, C.-C. et al. Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc. Natl. Acad. Sci. USA. 101, 4047\u20134052 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"6066_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2005.06.012","volume":"122","author":"H Tsuda","year":"2005","unstructured":"Tsuda, H. et al. The AXH domain of ataxin-1 mediates neurodegeneration through its interaction with Gfi-1\/senseless proteins. Cell 122, 633\u2013644 (2005).","journal-title":"Cell"},{"key":"6066_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.cell.2006.11.038","volume":"127","author":"YC Lam","year":"2006","unstructured":"Lam, Y. C. et al. ATAXIN-1 Interacts with the Repressor Capicua in Its Native Complex to Cause SCA1 Neuropathology. Cell 127, 1335\u20131347 (2006).","journal-title":"Cell"},{"key":"6066_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1101\/gad.212068.112","volume":"27","author":"E Kim","year":"2013","unstructured":"Kim, E., Lu, H. C., Zoghbi, H. Y. & Song, J. J. Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein ataxin-1 and Capicua. Genes Dev. 27, 590\u2013595 (2013).","journal-title":"Genes Dev."},{"key":"6066_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0896-6273(02)00697-9","volume":"34","author":"H Okazawa","year":"2002","unstructured":"Okazawa, H. et al. Interaction between Mutant Ataxin-1 and PQBP-1 Affects Transcription and Cell Death. Neuron 34, 701\u2013713 (2002).","journal-title":"Neuron"},{"key":"6066_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.neuron.2016.02.011","volume":"89","author":"M Ingram","year":"2016","unstructured":"Ingram, M. et al. Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways. Neuron 89, 1194\u20131207 (2016).","journal-title":"Neuron"},{"key":"6066_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.neuron.2018.02.013","volume":"97","author":"MWC Rousseaux","year":"2018","unstructured":"Rousseaux, M. W. C. et al. ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism. Neuron 97, 1235\u20131243.e5 (2018).","journal-title":"Neuron"},{"key":"6066_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.coi.2018.06.009","volume":"54","author":"LEM Heeb","year":"2018","unstructured":"Heeb, L. E. M., Egholm, C., Impellizzieri, D., Ridder, F. & Boyman, O. Regulation of neutrophils in type 2 immune responses. Curr. Opin. Immunol. 54, 115\u2013122 (2018).","journal-title":"Curr. Opin. Immunol."},{"key":"6066_CR20","doi-asserted-by":"crossref","unstructured":"Egholm, C., Heeb, L. E. M., Impellizzieri, D. & Boyman, O. The Regulatory Effects of Interleukin-4 Receptor Signaling on Neutrophils in Type 2 Immune Responses. Front. Immunol. 10, 2507 (2019).","DOI":"10.3389\/fimmu.2019.02507"},{"key":"6066_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.immuni.2016.06.025","volume":"45","author":"J Woytschak","year":"2016","unstructured":"Woytschak, J. et al. Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation. Immunity 45, 172\u2013184 (2016).","journal-title":"Immunity"},{"key":"6066_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41435-020-0095-7","volume":"21","author":"LEM Heeb","year":"2020","unstructured":"Heeb, L. E. M., Egholm, C. & Boyman, O. Evolution and function of interleukin-4 receptor signaling in adaptive immunity and neutrophils. Genes Immun 21, 143\u2013149 (2020).","journal-title":"Genes Immun"},{"key":"6066_CR23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/279523a0","volume":"279","author":"PJ FARRELL","year":"1979","unstructured":"FARRELL, P. J., BROEZE, R. J. & LENGYEL, P. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells. Nature 279, 523\u2013525 (1979).","journal-title":"Nature"},{"key":"6066_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1073\/pnas.72.1.11","volume":"72","author":"G Goldstein","year":"1975","unstructured":"Goldstein, G. et al. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc. Natl. Acad. Sci. USA 72, 11\u201315 (1975).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6066_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuroscience.2015.01.003","volume":"289","author":"M Cvetanovic","year":"2015","unstructured":"Cvetanovic, M., Ingram, M., Orr, H. & Opal, P. Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1. Neuroscience 289, 289\u2013299 (2015).","journal-title":"Neuroscience"},{"key":"6066_CR26","doi-asserted-by":"publisher","first-page":"16412","DOI":"10.1073\/pnas.182426899","volume":"99","author":"H Sakahira","year":"2002","unstructured":"Sakahira, H., Breuer, P., Hayer-Hartl, M. K. & Hartl, F. U. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity. Proc Natl Acad Sci USA 99, 16412\u201316418 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"6066_CR27","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/nm1066","volume":"10","author":"CA Ross","year":"2004","unstructured":"Ross, C. A. & Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 10, S10 (2004).","journal-title":"Nat. Med."},{"key":"6066_CR28","doi-asserted-by":"crossref","unstructured":"Cummings, C. J. et al. Chaperone Suppression of Aggregation and Altered Subcellular Proteasome Localization Imply Protein Misfolding in SCA1. vol. 19 http:\/\/genetics.nature.com (1998).","DOI":"10.1038\/502"},{"key":"6066_CR29","doi-asserted-by":"publisher","first-page":"4530","DOI":"10.1093\/hmg\/ddr394","volume":"20","author":"T Yagi","year":"2011","unstructured":"Yagi, T. et al. Modeling familial Alzheimer\u2019s disease with induced pluripotent stem cells. Hum. Mol. Genet. 20, 4530\u20134539 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"6066_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","volume":"12","author":"T Kondo","year":"2013","unstructured":"Kondo, T. et al. Modeling Alzheimer\u2019s disease with iPSCs reveals stress phenotypes associated with intracellular A\u03b2 and differential drug responsiveness. Cell Stem Cell 12, 487\u2013496 (2013).","journal-title":"Cell Stem Cell"},{"key":"6066_CR31","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1038\/s41380-018-0253-8","volume":"23","author":"H Tanaka","year":"2018","unstructured":"Tanaka, H. et al. The intellectual disability gene PQBP1 rescues Alzheimer\u2019s disease pathology. Mol. Psychiatry 23, 2090\u20132110 (2018).","journal-title":"Mol. Psychiatry"},{"key":"6066_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/ncb1553","volume":"9","author":"M-L Qi","year":"2007","unstructured":"Qi, M.-L. et al. Proteome analysis of soluble nuclear proteins reveals that HMGB1\/2 suppress genotoxic stress in polyglutamine diseases. Nat. Cell Biol. 9, 402\u2013414 (2007).","journal-title":"Nat. Cell Biol."},{"key":"6066_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15252\/emmm.201404392","volume":"7","author":"H Ito","year":"2015","unstructured":"Ito, H. et al. HMGB1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin\u20101 knock\u2010in mice. EMBO Mol. Med. 7, 78\u2013101 (2015).","journal-title":"EMBO Mol. Med."},{"key":"6066_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"6066_CR35","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1101\/gad.1664408","volume":"22","author":"B Zhao","year":"2008","unstructured":"Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962\u20131971 (2008).","journal-title":"Genes Dev."},{"key":"6066_CR36","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"F-X Yu","year":"2015","unstructured":"Yu, F.-X., Zhao, B. & Guan, K.-L. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell 163, 811\u2013828 (2015).","journal-title":"Cell"},{"key":"6066_CR37","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nm.2494","volume":"17","author":"M Cvetanovic","year":"2011","unstructured":"Cvetanovic, M., Patel, J. M., Marti, H. H., Kini, A. R. & Opal, P. Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1. Nat. Med. 17, 1445\u20131447 (2011).","journal-title":"Nat. Med."},{"key":"6066_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/srep12704","volume":"5","author":"J-B Fan","year":"2015","unstructured":"Fan, J.-B. et al. Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis. Sci. Rep. 5, 12704 (2015).","journal-title":"Sci. Rep."},{"key":"6066_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0896-6273(02)00733-X","volume":"34","author":"K Watase","year":"2002","unstructured":"Watase, K. et al. A Long CAG Repeat in the Mouse Sca1 Locus Replicates SCA1 Features and Reveals the Impact of Protein Solubility on Selective Neurodegeneration. Neuron 34, 905\u2013919 (2002).","journal-title":"Neuron"},{"key":"6066_CR40","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0092-8674(95)90273-2","volume":"82","author":"EN Burright","year":"1995","unstructured":"Burright, E. N. et al. SCA1 transgenic mice: A model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 82, 937\u2013948 (1995).","journal-title":"Cell"},{"key":"6066_CR41","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.tim.2017.01.001","volume":"25","author":"W Wang","year":"2017","unstructured":"Wang, W., Xu, L., Su, J., Peppelenbosch, M. P. & Pan, Q. Transcriptional Regulation of Antiviral Interferon-Stimulated Genes. Trends Microbiol. 25, 573\u2013584 (2017).","journal-title":"Trends Microbiol."},{"key":"6066_CR42","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1021\/acs.bioconjchem.0c00026","volume":"31","author":"E Eid","year":"2020","unstructured":"Eid, E. et al. Total Chemical Synthesis of ISGylated-Ubiquitin Hybrid Chain Assisted by Acetamidomethyl Derivatives with Dual Functions. Bioconjug. Chem. 31, 889\u2013894 (2020).","journal-title":"Bioconjug. Chem."},{"key":"6066_CR43","doi-asserted-by":"publisher","first-page":"e156616","DOI":"10.1172\/JCI156616","volume":"132","author":"W-S Lee","year":"2022","unstructured":"Lee, W.-S. et al. Cross-species genetic screens identify transglutaminase 5 as a regulator of polyglutamine-expanded ataxin-1. J. Clin. Invest. 132, e156616 (2022).","journal-title":"J. Clin. Invest."},{"key":"6066_CR44","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1460-9568.2006.04669.x","volume":"23","author":"R Luj\u00e1n","year":"2006","unstructured":"Luj\u00e1n, R. & Shigemoto, R. Localization of metabotropic GABA receptor subunits GABAB1 and GABAB2 relative to synaptic sites in the rat developing cerebellum. Eur. J. Neurosci. 23, 1479\u20131490 (2006).","journal-title":"Eur. J. Neurosci."},{"key":"6066_CR45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fncel.2018.00206","volume":"12","author":"H Konishi","year":"2018","unstructured":"Konishi, H. & Kiyama, H. Microglial TREM2\/DAP12 Signaling: A Double-Edged Sword in Neural Diseases. Front. Cell Neurosci. 12, 206 (2018).","journal-title":"Front. Cell Neurosci."},{"key":"6066_CR46","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00401-017-1668-z","volume":"133","author":"H Takahashi","year":"2017","unstructured":"Takahashi, H. et al. Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network. Acta. Neuropathol 133, 785\u2013807 (2017).","journal-title":"Acta. Neuropathol"},{"key":"6066_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13144-y","volume":"10","author":"Q Wang","year":"2019","unstructured":"Wang, Q. et al. The landscape of multiscale transcriptomic networks and key regulators in Parkinson\u2019s disease. Nat. Commun. 10, 5234 (2019).","journal-title":"Nat. Commun."},{"key":"6066_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15644-8","volume":"11","author":"S Garofalo","year":"2020","unstructured":"Garofalo, S. et al. Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis. Nat. Commun. 11, 1773 (2020).","journal-title":"Nat. Commun."},{"key":"6066_CR49","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1093\/hmg\/ddv202","volume":"24","author":"T Aikawa","year":"2015","unstructured":"Aikawa, T. et al. Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model. Hum. Mol. Genet. 24, 4780\u20134791 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"6066_CR50","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00401-017-1737-3","volume":"134","author":"J-V Haure-Mirande","year":"2017","unstructured":"Haure-Mirande, J.-V. et al. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer\u2019s pathology. Acta. Neuropathol. 134, 769\u2013788 (2017).","journal-title":"Acta. Neuropathol."},{"key":"6066_CR51","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s12276-020-00505-7","volume":"52","author":"RH Earls","year":"2020","unstructured":"Earls, R. H. & Lee, J.-K. The role of natural killer cells in Parkinson\u2019s disease. Exp. Mol. Med. 52, 1517\u20131525 (2020).","journal-title":"Exp. Mol. Med."},{"key":"6066_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s43587-023-00550-7","volume":"4","author":"BM Tijms","year":"2024","unstructured":"Tijms, B. M. et al. Cerebrospinal fluid proteomics in patients with Alzheimer\u2019s disease reveals five molecular subtypes with distinct genetic risk profiles. Nat. Aging 4, 33\u201347 (2024).","journal-title":"Nat. Aging"},{"key":"6066_CR53","doi-asserted-by":"crossref","unstructured":"Perng, Y. C. & Lenschow, D. J. ISG15 in antiviral immunity and beyond. Nat. Rev. Microbiol. 16, 423\u2013439 (2018).","DOI":"10.1038\/s41579-018-0020-5"},{"key":"6066_CR54","doi-asserted-by":"publisher","first-page":"9976","DOI":"10.1074\/jbc.M109078200","volume":"277","author":"MP Malakhov","year":"2002","unstructured":"Malakhov, M. P., Malakhova, O. A., Il Kim, K., Ritchie, K. J. & Zhang, D. E. UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277, 9976\u20139981 (2002).","journal-title":"J. Biol. Chem."},{"key":"6066_CR55","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature13801","volume":"517","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Human intracellular ISG15 prevents interferon-\u03b1\/\u03b2 over-amplification and auto-inflammation. Nature 517, 89\u201393 (2015).","journal-title":"Nature"},{"key":"6066_CR56","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/cells11030538","volume":"11","author":"O Mirzalieva","year":"2022","unstructured":"Mirzalieva, O., Juncker, M., Schwartzenburg, J. & Desai, S. ISG15 and ISGylation in Human Diseases. Cells 11, 538 (2022).","journal-title":"Cells"},{"key":"6066_CR57","first-page":"443","volume":"56","author":"C Siddoo-Atwal","year":"1996","unstructured":"Siddoo-Atwal, C., Haas, A. L. & Rosin, M. P. Elevation of interferon beta-inducible proteins in ataxia telangiectasia cells. Cancer Res. 56, 443\u2013447 (1996).","journal-title":"Cancer Res."},{"key":"6066_CR58","doi-asserted-by":"publisher","first-page":"e16422","DOI":"10.1371\/journal.pone.0016422","volume":"6","author":"LM Wood","year":"2011","unstructured":"Wood, L. M. et al. A Novel Role for ATM in Regulating Proteasome-Mediated Protein Degradation through Suppression of the ISG15 Conjugation Pathway. PLoS One 6, e16422 (2011).","journal-title":"PLoS One"},{"key":"6066_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2021.166102","volume":"1867","author":"M Juncker","year":"2021","unstructured":"Juncker, M. et al. ISG15 attenuates post-translational modifications of mitofusins and congression of damaged mitochondria in Ataxia Telangiectasia cells. Biochim. Biophys. Acta. Mol. Basis Dis. 1867, 166102 (2021).","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"6066_CR60","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1074\/jbc.M112.403832","volume":"288","author":"SD Desai","year":"2013","unstructured":"Desai, S. D., Reed, R. E., Babu, S. & Lorio, E. A. ISG15 Deregulates Autophagy in Genotoxin-treated Ataxia Telangiectasia Cells. J. Biol Chem 288, 2388\u20132402 (2013).","journal-title":"J. Biol Chem"},{"key":"6066_CR61","doi-asserted-by":"publisher","first-page":"160193","DOI":"10.1098\/rsob.160193","volume":"6","author":"E Im","year":"2016","unstructured":"Im, E., Yoo, L., Hyun, M., Shin, W. H. & Chung, K. C. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin. Open Biol. 6, 160193 (2016).","journal-title":"Open Biol."},{"key":"6066_CR62","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/jnen\/nly129","volume":"78","author":"J Schwartzenburg","year":"2019","unstructured":"Schwartzenburg, J., Juncker, M., Reed, R. & Desai, S. Increased ISGylation in Cases of TBI-Exposed ALS Veterans. J. Neuropathol. Exp. Neurol. 78, 209\u2013218 (2019).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"6066_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0138-9","volume":"9","author":"L Yoo","year":"2018","unstructured":"Yoo, L., Yoon, A.-R., Yun, C.-O. & Chung, K. C. Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon. Cell Death Dis. 9, 97 (2018).","journal-title":"Cell Death Dis."},{"key":"6066_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13588","volume":"7","author":"C Villarroya-Beltri","year":"2016","unstructured":"Villarroya-Beltri, C. et al. ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins. Nat. Commun. 7, 13588 (2016).","journal-title":"Nat. Commun."},{"key":"6066_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19737-2","volume":"11","author":"M Olah","year":"2020","unstructured":"Olah, M. et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u2019s disease. Nat. Commun. 11, 6129 (2020).","journal-title":"Nat. Commun."},{"key":"6066_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02618-4","volume":"19","author":"BDS Clarkson","year":"2022","unstructured":"Clarkson, B. D. S., Grund, E., David, K., Johnson, R. K. & Howe, C. L. ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation. J. Neuroinflamm. 19, 258 (2022).","journal-title":"J. Neuroinflamm."},{"key":"6066_CR67","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.4049\/jimmunol.146.7.2280","volume":"146","author":"E Knight","year":"1991","unstructured":"Knight, E. IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. J. Immunol. 146, 2280\u20132284 (1991).","journal-title":"J. Immunol."},{"key":"6066_CR68","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.4049\/jimmunol.147.8.2617","volume":"147","author":"M Recht","year":"1991","unstructured":"Recht, M. A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J. Immunol. 147, 2617\u20132623 (1991).","journal-title":"J. Immunol."},{"key":"6066_CR69","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1073\/pnas.93.1.211","volume":"93","author":"J D\u2019Cunha","year":"1996","unstructured":"D\u2019Cunha, J., Knight, E., Haas, A. L., Truitt, R. L. & Borden, E. C. Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc. Natl. Acad. Sci. USA 93, 211\u2013215 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"6066_CR70","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.molcel.2017.10.003","volume":"68","author":"CD Swaim","year":"2017","unstructured":"Swaim, C. D., Scott, A. F., Canadeo, L. A. & Huibregtse, J. M. Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor. Mol Cell 68, 581\u2013590.e5 (2017).","journal-title":"Mol Cell"},{"key":"6066_CR71","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41586-023-05788-0","volume":"615","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy. Nature 615, 668\u2013677 (2023).","journal-title":"Nature"},{"key":"6066_CR72","first-page":"1684","volume":"337","author":"D Bogunovic","year":"2012","unstructured":"Bogunovic, D. et al. Mycobacterial Disease and Impaired IFN-\u03b3 Immunity in Humans with Inherited ISG15 Deficiency. Science (1979) 337, 1684\u20131688 (2012).","journal-title":"Science (1979)"},{"key":"6066_CR73","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1101\/gad.1010202","volume":"16","author":"KJ Ritchie","year":"2002","unstructured":"Ritchie, K. J. et al. Dysregulation of protein modification by ISG15 results in brain cell injury. Genes Dev. 16, 2207\u20132212 (2002).","journal-title":"Genes Dev."},{"key":"6066_CR74","doi-asserted-by":"publisher","first-page":"19871","DOI":"10.1074\/jbc.M100034200","volume":"276","author":"J You","year":"2001","unstructured":"You, J. & Pickart, C. M. A HECT Domain E3 Enzyme Assembles Novel Polyubiquitin Chains. J. Biol. Chem. 276, 19871\u201319878 (2001).","journal-title":"J. Biol. Chem."},{"key":"6066_CR75","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molcel.2015.01.042","volume":"58","author":"MA Michel","year":"2015","unstructured":"Michel, M. A. et al. Assembly and specific recognition of K29- and K33-linked polyubiquitin. Mol. Cell 58, 95\u2013109 (2015).","journal-title":"Mol. Cell"},{"key":"6066_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molcel.2015.01.041","volume":"58","author":"YA Kristariyanto","year":"2015","unstructured":"Kristariyanto, Y. A. et al. K29-selective ubiquitin binding domain reveals structural basis of specificity and heterotypic nature of K29 polyubiquitin. Mol. Cell 58, 83\u201394 (2015).","journal-title":"Mol. Cell"},{"key":"6066_CR77","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/embj.201386906","volume":"33","author":"HC Besche","year":"2014","unstructured":"Besche, H. C. et al. Autoubiquitination of the 26S Proteasome on Rpn13 Regulates Breakdown of Ubiquitin Conjugates. EMBO J. 33, 1159\u20131176 (2014).","journal-title":"EMBO J."},{"key":"6066_CR78","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nsmb.2169","volume":"19","author":"JDF Licchesi","year":"2012","unstructured":"Licchesi, J. D. F. et al. An ankyrin-repeat ubiquitin-binding domain determines TRABID\u2019s specificity for atypical ubiquitin chains. Nat. Struct. Mol. Biol. 19, 62\u201372 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"6066_CR79","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/ni.3347","volume":"17","author":"J Jin","year":"2016","unstructured":"Jin, J. et al. Epigenetic regulation of the expression of Il12 and Il23 and autoimmune inflammation by the deubiquitinase Trabid. Nat. Immunol. 17, 259\u2013268 (2016).","journal-title":"Nat. Immunol."},{"key":"6066_CR80","doi-asserted-by":"crossref","unstructured":"Swatek, K. N. & Komander, D. Ubiquitin modifications. Cell Res. 26, 399\u2013422 (2016).","DOI":"10.1038\/cr.2016.39"},{"key":"6066_CR81","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","volume":"14","author":"H Jacobi","year":"2015","unstructured":"Jacobi, H. et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol. 14, 1101\u20131108 (2015).","journal-title":"Lancet Neurol."},{"key":"6066_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-177","volume":"8","author":"T Ashizawa","year":"2013","unstructured":"Ashizawa, T. et al. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet. J. Rare Dis. 8, 177 (2013).","journal-title":"Orphanet. J. Rare Dis."},{"key":"6066_CR83","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/mds.23809","volume":"26","author":"Ychung Lee","year":"2011","unstructured":"Lee, Ychung et al. Comparison of cerebellar ataxias: A three-year prospective longitudinal assessment. Mov. Disord. 26, 2081\u20132087 (2011).","journal-title":"Mov. Disord."},{"key":"6066_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0118-4","volume":"9","author":"K Yasui","year":"2014","unstructured":"Yasui, K. et al. A 3-year cohort study of the natural history of spinocerebellar ataxia type 6 in Japan. Orphanet. J. Rare Dis. 9, 118 (2014).","journal-title":"Orphanet. J. Rare Dis."},{"key":"6066_CR85","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s00415-020-09815-2","volume":"268","author":"A Diallo","year":"2021","unstructured":"Diallo, A., Jacobi, H., Tezenas du Montcel, S. & Klockgether, T. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis. J. Neurol. 268, 2749\u20132756 (2021).","journal-title":"J. Neurol."},{"key":"6066_CR86","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2117","volume":"10","author":"N Bektas","year":"2008","unstructured":"Bektas, N. et al. The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Res. 10, R58 (2008).","journal-title":"Breast Cancer Res."},{"key":"6066_CR87","doi-asserted-by":"crossref","unstructured":"Tanaka, H. et al. HMGB1 signaling phosphorylates Ku70 and impairs DNA damage repair in Alzheimer\u2019s disease pathology. Commun. Biol. 4, 1175 (2021).","DOI":"10.1038\/s42003-021-02671-4"},{"key":"6066_CR88","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.celrep.2016.10.026","volume":"17","author":"Y Ishida","year":"2016","unstructured":"Ishida, Y. et al. Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 Patient-Derived iPSCs. Cell Rep. 17, 1482\u20131490 (2016).","journal-title":"Cell Rep."},{"key":"6066_CR89","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"6066_CR90","first-page":"508","volume":"34","author":"T Hanihara","year":"1994","unstructured":"Hanihara, T., Takahashi, T., Inoue, K., Yamada, Y. & Iwabuchi, K. Siblings with spinocerebellar ataxia type 1 (SCA1)-diagnosis by detecting the expansion of CAG repeat on chromosome 6p. Rinsho Shinkeigaku 34, 508\u2013510 (1994).","journal-title":"Rinsho Shinkeigaku"},{"key":"6066_CR91","first-page":"21","volume":"11","author":"K Iwabuchi","year":"1991","unstructured":"Iwabuchi, K., Yagishita, S., Amano, N. & Kosaka, K. An autopsied case of autosomal doinant hereditary spinocerebellar degeneration with atrophies in multiple systems. Neuropathology 11, 21\u201330 (1991).","journal-title":"Neuropathology"},{"key":"6066_CR92","first-page":"255","volume":"155","author":"K Iwabuchi","year":"1999","unstructured":"Iwabuchi, K., Tsuchiya, K., Uchihara, T. & Yagishita, S. Autosomal dominant spinocerebellar degenerations. Clinical, pathological, and genetic correlations. Rev. Neurol. (Paris) 155, 255\u2013270 (1999).","journal-title":"Rev. Neurol. (Paris)"},{"key":"6066_CR93","doi-asserted-by":"publisher","unstructured":"Homma, H. & Okazawa, H. hmmhdnr\/iMAD: Custom code for iMAD-based molecular network analysis. Zenodo https:\/\/doi.org\/10.5281\/zenodo.10820842 (2024).","DOI":"10.5281\/zenodo.10820842"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06066-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06066-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T06:14:54Z","timestamp":1712643294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06066-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6066"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06066-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,9]]},"assertion":[{"value":"3 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}